Provectus Biopharmaceuticals, Inc. announced it raised $200,000 in an initial filing from an offering of $5 Million

Aug 31, 2021•almost 4 years ago

Amount Raised

$200,000

Round Type

pre-seed

KnoxvilleHealthcare

Company Information

Company

PROVECTUS BIOPHARMACEUTICALS, INC.

Location

800 S. GAY STREET

Knoxville, Tennessee, United States

About

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Provectus Biopharmaceuticals, Inc. announced it raised $200,000 in an initial filing from an offering of $5 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information